Human-steered next-generation machine learning for reviving drug design

Bidragets beskrivning

The aim of this project is to develop machine learning methods that enable reviving drug development, which has currently been significantly slowed down due to a huge increase of development cost. We develop new methods, with which drug design can take into account both the enlarging measurement databases and expertise of the drug developers. The methods will be general-purpose, and will be taken into use widely in other fields as well, in the Finnish Center for Artificial Intelligence FCAI where the research will be carried out.
Visa mer

Startår

2021

Slutår

2025

Beviljade finansiering


Vikas Garg
479 905 €

Rollen i Finlands Akademis konsortium

Partner

Övriga parter i konsortiet

Leader
Aalto-universitetet (341763)
479 905 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiprojekt

Övriga uppgifter

Finansieringsbeslutets nummer

342077

Vetenskapsområden

Data- och informationsvetenskap

Forskningsområden

Laskennallinen data-analyysi

Identifierade teman

bioinformatics